Purpose The study serves to optimise conditions for multipinhole SPECT small animal imaging of 123 I-and 99m Tclabelled radiopharmaceuticals with different distributions in murine heart and brain and to investigate detection and dose range thresholds for verification of differences in tracer uptake. Tc-labelled tracers in an appropriate dose range in murine models targeting physiological processes in brain and heart. The thresholds of detection for differences in the tracer uptake determined under the conditions of our experiments well reflect distinctions in molar activity and uptake characteristics of the tracers.
Tc-labelled tracers in an appropriate dose range in murine models targeting physiological processes in brain and heart. The thresholds of detection for differences in the tracer uptake determined under the conditions of our experiments well reflect distinctions in molar activity and uptake characteristics of the tracers.
Introduction
During the last decade multi-pinhole SPECT systems of various designs have been proposed for use in preclinical research and also for some clinical applications [1] [2] [3] [4] [5] [6] [7] [8] [9] .
Multi-pinhole designs for SPECT applications range from systems with a few detectors using collimators with a large number of pinholes, which do not reduce the counting rate substantially and allow for high time resolution, to systems with several detectors using collimators with only a few pinholes, or alternatively, annular detectors, with emphasis on improvement of the spatial resolution. Clinical applications of such systems have been proposed for the assessment of alterations due to hyperplastic parathyroid glands [7, 10] and for diagnosis of rheumatism, arthrosis [5] and coronary heart disease [8] .
In preclinical research, multi-pinhole SPECT is developing into a complement to PET as a tool for in vivo imaging of pharmacodynamics and pharmacokinetics of receptor ligands [11] , tracers of metabolic processes [12, 13] and physiological properties in healthy and diseased small animals [3, [14] [15] [16] [17] . Dedicated SPECT and PET systems can provide sufficient spatial and temporal resolution for quantitative observation of such processes even in mouse models.
The high availability of SPECT radiopharmaceuticals, increasing experience with SPECT tracers in small animal imaging [3, 4, 13, [18] [19] [20] [21] [22] and improvement of resolution parameters of SPECT with multi-pinhole devices contribute to broadening the role that multi-pinhole SPECT (MPS) is able to play in small animal imaging. The use of a broad range of tracers is especially important for the study of transgenic mouse models, which have become an essential tool of biological research during the last two decades.
Due to the high variety of gamma cameras applied to small animal imaging, reproducibility of experiments requires a detailed description of the visualisation conditions used for different tracers, requirements of tracer dose and technical parameters of the SPECT devices, sensitivity as well as geometric properties of the animal model investigated [4, 23, 24] .
The present study focuses on the evaluation of the parameters required for the imaging of mouse brains and hearts using different tracers and animal models and a MPS including three 6-pinhole collimators. To this aim, the definition of the dose range for different tracers and the quantitative assessment of detection borders of anatomical and molecular alterations were performed in physiological and pathophysiological mouse models by means of the MPS. We investigated the biodistribution of the dopamine D 2 [29] . Although the prostaglandin EP 3 receptor is known to mediate cardiac protection during ischaemia and reperfusion, the development of cardiac hypertrophy has been observed in these animals. The recent investigations contribute to the further characterisation of the physiological and metabolic phenotype of these hearts on the one hand as well as to the estimation of the borders of detection of alterations in the uptake of radiopharmaceuticals in normal tissues and under pathophysiological conditions on the other hand. Two data processing tools are compared for their abilities in assessment of the SPECT imaging data. Localisation of anatomical structures and assessment of alterations in their size is supported by MR imaging of brain and heart. For the SPECT measurements a Triad 88 system upgraded with 6-pinhole collimators with an average sensitivity of 835 cps/MBq and an inner diameter of 1.5 mm was used as described previously [2, 30] .
Materials and methods

Chemicals
Animals
All animals were obtained from Charles River Deutschland GmbH (Sulzfeld, Germany) (NMRI mice) or the Animal Care Unit of the Heinrich Heine University Düsseldorf [B6C3F1-Tg(EP3)].
Mice with cardiac-specific overexpression of the porcine homologue of the human G i /G q -coupled EP 3II receptor subtype under control of the α-myosin heavy chain (α-MHC) promoter were generated using standard techniques as described previously [29] .
The animals were kept at 12/12-h dark-light cycles. All procedures were performed in accordance with the German Guidelines for Care and Use of Laboratory Animals and approved by the governmental Animal Research Committee.
General experimental procedure
The investigations were performed in 24 animals (7 NMRI: 34-50 g body weight; 17 B6C3F1(EP3), 7 transgenic, 10 wild-type; 18-30 g). For the SPECT experiments and for brain MRI the mice were anaesthetised using ketamine/ xylazine (i.p. application of 100 mg/10 mg per 100 g body weight and hour). Anaesthesia was started 15 min before injection of the radiopharmaceuticals. For the SPECT investigations a plastic v-notch was placed in the mouth approximately 5 min after start of anaesthesia to ensure that obstruction of the upper respiratory tract was avoided.
All radiopharmaceuticals were injected via the tail vein. For the brain SPECT the mice were placed in prone position and for the cardiac SPECT in supine position in an animal bed in the centre of the multi-pinhole SPECT system. At the end of the observation period the brains and 11 of the hearts were excised and the activity was measured immediately by means of an Activimeter Isomed 1000 (Version 2.30, Nuklear-Medizintechnik Dresden GmbH, Dresden, Germany). Subsequently, the excised organs were scanned ex vivo (four brains and four [ 99m Tc]-sestamibi labelled hearts) by means of the MPS camera system with the same acquisition time as used for the last in vivo measurement.
The anaesthesia during MRI of the brain was the same as for the SPECT investigations. For cardiac MRI the animals were anaesthetised with 1.5% isoflurane in a gas mixture of 30% oxygen in nitrogen.
Brain SPECT 
Reconstruction and quantification
The reconstruction of the images was performed using HISPECT multi-pinhole reconstruction software (Scivis GmbH , Göttingen, Germany). Quantification of the activity accumulated in volumes of interest and regions of interest (ROI), respectively, was performed with Vinci 2.3.1. [31] and InVivoScope processing tools (courtesy of Dr. Christian Lackas) as described previously [32] . Standard uptake values (SUV) were calculated according to the equation: SUV = activity per g target tissue/activity applied per animal * g body weight [33, 34] . The segmental evaluation of the cardiac distribution of [ 99m Tc]sestamibi was performed choosing the ROIs as described previously [35] . The quantification of cardiac uptake using the InVivoScope processing tool was performed by determination of the sum of intensity signals within the whole heart. In contrast, the calculation of the intensity by means of the Vinci processing tool was performed by determination of the intensities measured in the wall of the left ventricle in short axis view, horizontal long axis view and vertical long axis view and evaluation of the total intensity in the apparent volume of the left ventricle using these data.
MR imaging of brain and heart MR brain imaging was performed using a 9.4 T animal scanner based on a horizontal superconducting magnet (Magnex, Scientific Ltd., Yarnton, UK) with a bore size of 16 cm equipped with a 10-cm inner diameter gradient coil and a gradient strength of 270 mT/m [30] . A 20-mm surface coil was used for both excitation and signal detection.
Cardiac MR imaging was performed using a vertical Bruker DRX 9.4 T NMR spectrometer, with a 40-mm gradient set (maximum strength 1 T/m) and a 30-mm birdcage resonator. The images were acquired using an ECG-and respiration-gated gradient echo cine sequence (repetition time of 5 ms, echo time 2.5 ms, flip angle 15°, field of view 30×30 mm 2 , reconstruction matrix site 256× 256, slice thickness = 1 mm).
Statistical analysis
Results are expressed as mean ± standard error of mean (SEM). Significance of differences between several groups were identified using one-way analysis of variance (ANOVA) followed by the Student-Newman-Keuls test for multiple comparison. Comparison between two groups was performed using a paired and an unpaired Student's t test. Pearson's coefficient was used to test the significance of correlations between the data obtained. A probability value less than 0.05 was considered significant. The evaluation of uptake of [ 123 I]IBZM by means of the Vinci 2.3.1. processing tool shown in Fig. 3a was performed using a volume-based approach as described earlier [30] . Figure 3b presents the respective data obtained by means of the InVivoScope processing tool. The proportion between specific and non-specific binding related to the total volume of the brain decreased from 1:5 to values > 1 at the 100th min of the observation period (fifth acquisition period; data not shown). A comparison of the data points obtained for the four doses (for each dose mean value of all acquisition periods with exception of period 2 and 6) using ANOVA followed by the StudentNewman-Keuls post hoc test (Fig. 4a, b ) reveals the range in which the multi-pinhole system reflects differences in the uptake of the receptor ligand under the experimental condition described. Differences between the mean values obtained using the Vinci 2.3.1. processing tool were identified as significant upward from 20% of the uptake at the maximal dose activities applied. The same uptake was reflected with a 30% difference (610 kBq/g body weight and 510 kBq/g body weight obtaining group) but with the same probability of significance with the InVivoScope processing tool. Figure 5 shows good correlations between activity measurements of excised brains in vitro and the intensity values observed in vivo ( ]IBZM/g body weight were applied. SPECT measurement was performed using acquisition times of 100 s and 10 steps of rotation. 1 position of the harderian glands, 2 position of the striata acquisition period (Fig. 5b) and for the eighth acquisition period (Fig. 5c) .
Results
The activities applied in the present experiments were in accordance with the range proposed by the modified Goertzen equation [4, 30] . Moreover, Eq. 1 allows a simple estimation of the activity necessary for equivalent visualisation of [
123 I]IBZM binding (or ligands with similar cerebral uptake behaviour) to striata in different species with different brain and body weights.
A2 activity to apply to the animal of the second species D1 tissue uptake in species 1 corresponding to the desired visualisation level ]IBZM uptake into murine striata. Mean ± SEM was calculated for each animal from 12 data points (right and left striata) involving six acquisition periods, when the complete set of intensity data at the four activity doses was available. *p<0.05 vs 950 kBq/g body weight. #p<0.05 vs 610 kBq/g body weight. ANOVA followed by the Student-Newman-Keuls test was used for statistical comparison. See Fig. 2 for further description of the imaging conditions . Maximum intensity projections of a have been shown in [30] BRwt1 brain weight of first species BRwt2 brain weight of second species BDwt2 body weight of second species Figure 6 shows these activities for different proportions of brain and body weights suggesting that an equivalent visualisation as in a 30-g mouse can be obtained in a rat of 300 g body weight, using only the 2-2.5-fold of the activity applied in mice although the proportion of the body weights is 1:10. This calculation however does not include the potential influence of further aspects such as species differences in distribution velocity of the tracers as described previously [33] or species differences in metabolism or carrier kinetics. Figure 7 (Fig. 9) .
The visualisation of [ 99m Tc]sestamibi in the heart required 4-10-fold higher doses than for the 123 I-labelled receptor ligands. Figure 10 shows a comparison between two hearts after application of the same activity (3.8 MBq/g Tc]sestamibi using the InVivoScope data processing tool, while data obtained by means of the Vinci 2.3.1. processing tool using only the intensities measured in the left ventricle in vivo showed a lower correlation coefficient (Fig. 12) .
The in vitro investigation of hearts from cardiomyopathic and wild-type littermates as well as the uptake of [ 99m Tc]sestamibi observed during SPECT imaging revealed a 30% reduction of the cardiac perfusion (Fig. 13) . The SUV were calculated referring to the percentage of the activity localised in the heart (InVivoScope, Fig. 12a ) to 1% of the body weight [25, 26] 
Discussion
The present study provides a first direct quantitative comparison of volume-based evaluation of in vivo imaging data and in vitro data on the uptake of SPECT tracers in murine brain and heart using [
123 I]IBZM and [ 99m Tc] sestamibi, respectively. Thresholds of detection are calculated for tracers with different distribution patterns in murine brain and in the heart, respectively, for the conditions of the multi-pinhole SPECT system employed. Moreover it is shown that the multi-pinhole SPECT method is able to identify differences in the range of 20% of the maximal uptake in the dose range between 950 kBq/g and 440 kBq/g employed in this study. The in vivo uptake of [26] [27] [28] 30] . That is due to the fact that dopamine D 2 receptors are found with a high density in the striatum as a compactly shaped telencephalic part of the brain, providing a well-defined volume of interest ranging from 30 to 60 mg (both striata in summary) in adult mice surrounded by a large zone of lower dopamine D 2 receptor density and relatively low nonspecific binding.
Evaluations of PET and SPECT in vivo imaging data in small animal models with the aim of developing algorithms for tracer quantification or coregistration with other imaging data have been described previously [24, [36] [37] [38] [39] [40] . The literature includes comparisons with autoradiographic measurements or other semi-quantitative reference tissue methods for brain, heart and some tumour models of different localisations [39, 41] . In our MPS [
123 I]IBZM measurements, the activity bound non-specifically in the whole brain decreases at the end of the observation period of 3 hs to 20% of the initial values, while the activity bound specifically reached an equilibrium during the fifth acquisition period. This is in agreement with the time course reported in a previous pinhole SPECT study of [ 123 I]IBZM in mouse models [28] as well as with an ex vivo study [40] . The imaging data evaluated with the InVivoScope and Vinci 2.3.1. data processing tools allowed us to distinguish differences upwards from 20% of maximal tracer amount accumulated in the brains in the dose range between 440 kBq/g and 950 kBq/g. The least-squares linear fit for the comparison of in vitro and in vivo uptake of [
123 I]IBZM allowed us to reveal that this percentage corresponds to a total cerebral activity of 116 kBq/g. The estimate involves the assumption that approximately 50% of the tracer detected in the brain binds to receptors in the striata. A lower ratio of striatal to total cerebral activity would result in higher activity values.
There are only a few reports on measurements of [ 123 I] IBZM in the murine brain using SPECT or multi-pinhole SPECT, respectively. More attention has been paid to ligands of dopamine transporters using [
123 I]FP-CIT or calculated for the two-tailed paired Student's t test. Calculation of standard uptake in vitro was performed using activities and weights determined in excised hearts. Calculation of in vivo data was performed using activities determined using the regression line in Fig. 12a referring to the apparent heart volume calculated by the InVivoScope tool. SUV in vitro is given without dimension and SUV in vivo has the dimension arbitrary units (InVivoScope)/MBq ]IBZM uptake and the assumption that at activities of ≤20 MBq/animal (in mice weighing 50-25 g) the concentration of IBZM stays below ED 50 , but for displacement studies with a low mass effect it is necessary to work with higher specific activities than the reference 74 TBq/mmol used in our calculations [30] . This reference is the lower boundary of the specific activity guaranteed by the manufacturer. The concentration in non-striatal cerebral tissue in the sample described above was 1.62 nmol/kg at the same time resulting in a ratio of specific to non-specific binding of 15. Meyer et al. [40] described a ratio of 17 in autoradiographic studies in mice if working with a ketamine/ xylazine (without isofluorane) anaesthesia comparable to that which we applied. The ratio was markedly lower if isoflurane was included in the anaesthesia. An occupancy below 5% can be achieved with higher specific activities as described recently [42] .
The dose-dependent increase in the uptake of [ 123 I] IBZM during the eight observation periods suggests that the activity doses applied are in the linear range of the doseresponse curve. This allowed identification of the border of detection for the difference in the uptake in regard to different injection doses without impairment by saturation effects.
The activity threshold for the visualisation of in vivo uptake in the brain for a tracer like [
123 I]IBZM with a small target region and a relatively high specific activity was 45 kBq (and 6 kBq ex vivo; data not shown; using 100 s acquisition time and 10 step rotation mode in our camera system) as revealed by the offset of the regression line for the comparison between in vivo and in vitro data at y=0. The comparison of the doses recommended to be applied in different species for several visualisation levels is verified for ligands of dopamine transporters and receptors in mice and rats by our own data. The results agree also with the calculations by Kung et al. [47, 48] . If measurements of species with larger geometric dimensions require a larger radius of rotation further correction factors are necessary. Weber et al. [49] described for a triple-headed pinhole SPECT system how spatial resolution and sensitivity change with the increase in the distance between detectors and target region. Taking these alterations into account for a special multi-pinhole system, also the doses necessary for equipotent visualisation would need an additional correction factor. An increased role of attenuation in larger species would also require further modification of the data [41] . For a tracer such as [ 99m Tc]HMPAO with homogeneous distribution through the target organ as well as a specific activity<5% [50] of that of the receptor ligand investigated in our study, the threshold of detection is 2-10-fold higher.
[ ,6,9-tetramethylundecane-2,10-dione bisoxime) is an uncharged, low molecular weight, lipophilic complex that easily crosses the blood-brain barrier [51] . It is known that in man 3-5 to 7% of HMPAO injected pass into the brain by passive diffusion during the first minutes after injection. In humans it remains for 24 h in the brain, probably trapped inside cells via a reaction with glutathione [52] , and is not preferentially bound to a specific region of the brain.
Cardiac investigations
Altered activity requirements were also revealed during the imaging of the perfusion tracer [ Tc]sestamibi is a cationic complex which is accumulated in tissues rich in mitochondria like liver and heart and trapped in the mitochondrial matrix [53] . Accumulations of 1.2% of the dose were reported for silent myocardium and 1.5% under stress [51] . The compound enters the heart by passive diffusion and correlates well with regional perfusion under conditions of normal load. It shows almost no redistribution [54] under these conditions, while its extraction at high coronary flow or under hypoxic conditions is not proportional to coronary perfusion [51] . In. Left ventricular visualisation of the tracers was obtained in a similar quality as in our experiments. Beekman et al. [58] were able to visualise murine heart perfusion with a submillimetre resolution after injection of 222 MBq [ 99m Tc]tetrofosmin. However, quantitative approaches to the correlation of in vivo SPECT data with in vitro measurements of the tracer uptake are rather available for sestamibi and other perfusion tracers in porcine and canine models [59, 60] . Da Silva et al. [60] drew an offset of 7-11 kBq/g heart weight from the correlation of in vivo SPECT data of [ 99m Tc]sestamibi uptake in porcine hearts with ex vivo data. That would give a detection threshold of 1 MBq total uptake for a 150-g heart. For our murine hearts in the multi-pinhole system we found a threshold of 200 kBq/heart. That corresponds for hearts with a size between 100 and 200 mg to 1-2 MBq/g. Compared to the offset found in the porcine model the threshold for the uptake per murine heart would be lower, but the offset per g heart weight would be 150-350-fold higher. However, the ratio of the body weights of mouse and pig would be 1:1,000.
Estimates of the whole-body dose in SPECT [61] are given with a range from less than 2 cGy (160 MBq of 99m Tc; biological half-life 1 h) in rats to 90 cGy (740 MBq in 30 g-mice assuming a residence time of 3.2 h) [41] . The activity of [
99m Tc]sestamibi applied in our experiment comprised maximally 30% of this amount and on average 15%. Funk et al. [61] reported theoretical values of the whole-body doses from phantom measurements corresponding to the conditions of biological experiments in the range between 6 and 90 cGy for mice and 1-27 cGy for rats and a LD 50 of 7 Gy/30 d for mice.
Transgenic B6C3F1(EP3) mice show an increase of left ventricular mass, end-diastolic and end-systolic volumes as well as a significant decrease in left ventricular ejection fraction and dP/dt, as found recently [29] . These alterations were already obvious in 5-to 7-week-old animals [29] . Our data support the maintenance of the cardiomyopathic alterations in the 11-to 17-week-old mice with 8.6± 0.36 mg heart weight/g body weight in comparison to 4.6±0.14 mg/g in wild-type littermates.
The [56] by an active process via a CD36 protein acting as a carrier of long chain fatty acids [14, 62] . It is not clear whether the paradoxical hypertrophic response of the heart to the overexpression of EP 3 receptors, which are known to mediate cardiac protection, is related to these processes. Although an increased phosphorylation of the S6 ribosomal protein has been observed, and it is known to correlate with an enhanced protein synthesis, the kind of relation between EP 3 overexpression and morphological and metabolic alterations associated with the cardiomyopathic properties of these hearts has not been characterised. In contrast, alterations in the parameters of contractility and cardiac function can be explained by mediation by the known signalling pathways via G i -coupled receptors. The imaging of the uptake of long chain fatty acids by MPS methods provides the possibility to investigate such regulatory processes and their metabolic consequences in vivo.
The present investigations support the theory that the multi-pinhole SPECT device in combination with suitable data processing tools is capable of visualising such alterations and quantifying metabolic processes and ligand binding in different target organs of mice in a feasible dose range. Recently, the quantitative approach which can be used in experimental models has received further support by a plenitude of reports concerning attenuation [63] , algorithms for improving reconstruction image quality [64, 65] , further improvement of the pinhole collimator design [66, 67] and multimodal approaches used for PET and SPECT investigations [36, 68] . The small scale of murine models is not only a disadvantage for visualisation, but also offers advantages for example in relation to the attenuation [41] . The multi-pinhole approach in contrast to small animal PET allows multi-isotope investigations and provides advantages by a more favourable whole-body dose during the use of SPECT isotopes in comparison to positron emitters, shown by favourable MIRD S values [61] , availability of SPECT isotopes and high specific activity for receptor and transporter ligands exceeding frequently those of PET radiopharmaceuticals. The rising availability of CT/SPECT as well as the use of a gated mode of measurements during cardiac investigations extend the access to in vivo information on biochemistry, molecular and cell biology as well as physiology.
